Sort
40,608 grants matching “prostate cancer”
CD24 AS A POTENTIAL THERAPEUTIC TARGET IN PROSTATE CANCER
$562,200Regents Of The University Of Michigan · · FY2008 · Department of the Army
Global genetic and epigenetic approaches to progression of PCa
$562,028Wennuan Liu · Wake Forest University Health Sciences · R01 · FY2009 · CA
Molecular Genomics Core
$561,998David W Craig · University Of Southern California · P30 · FY2024 · CA
HIGH-THROUGHPUT SCREEN OF ADVANCED PROSTATE CANCER ORGANOIDS AND PDX PRECLINICAL TRIALS TO IDENTIFY SINGLE AND COMBINATION THERAPIES CORRELATED WITH
$561,972University Of Washington · · FY2018 · Department of the Army
TARGETING THE HSP40/HSP70 MOLECULAR CHAPERONE AXIS AS A NOVEL TREATMENT STRATEGY FOR CASTRATE-RESISTANT PROSTATE CANCER
$561,864Regents Of The University Of California, San Francisco, The · · FY2016 · Department of the Army
Medical Care Burden of Cancer: System and Data Issues
$561,821Mark Christopher Hornbrook · Kaiser Foundation Research Institute · R01 · FY2010 · CA
Tumor immune and glycan biomarkers for progressive prostate cancer
$561,790Jennifer D Wu · Northwestern University At Chicago · R01 · FY2021 · CA
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi
$561,786Li Li · Case Western Reserve University · U01 · FY2014 · CA
Prostate Cancer Diagnosis by Multiparametric Ultrasound
$561,765Flemming Forsberg · Thomas Jefferson University · R01 · FY2023 · CA
MOLECULAR MECHANISMS AND THERAPEUTIC POTENTIAL OF THE HISTONE-MODIFYING ONCOGENE KDM4C IN CASTRATION-RESISTANT PROSTATE CANCER
$561,761Wayne State University · · FY2014 · Department of the Army
Administrative Core
$561,728Shafiq A Khan · Clark Atlanta University · U54 · FY2021 · MD
Career Development in Pediatric and Medical Oncology
$561,702Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2020 · CA
Genome-wide Copy Number Variation and Breast Cancer Risk
$561,690Jirong Long · Vanderbilt University · R01 · FY2012 · CA
Heparan Sulfate in Prostate Cancer
$561,653Lianchun Wang · University Of South Florida · U01 · FY2019 · CA
The microtubule cytoskeleton as a novel target for cavernous nerve regeneration after prostatectomy
$561,617Kelvin P Davies · Albert Einstein College Of Medicine · R01 · FY2019 · DK
The microtubule cytoskeleton as a novel target for cavernous nerve regeneration after prostatectomy
$561,617Kelvin P Davies · Albert Einstein College Of Medicine · R01 · FY2020 · DK
INCORPORATION OF NOVEL MRI AND BIOMARKERS INTO PROSTATE CANCER ACTIVE SURVEILLANCE RISK ASSESSMENT
$561,600The University Of Texas Health Science Center At San Antonio · · FY2015 · Department of the Army
PROTEIN-DEPENDENT ACTIVATION OF THE UNFOLDED PROTEIN RESPONSE (UPR) ENABLES PROSTATE CANCER DEVELOPMENT AND A DRUGGABLE TARGET FOR ADVANCE PROSTATE C
$561,600Regents Of The University Of California, San Francisco, The · · FY2015 · Department of the Army
GERMLINE VARIATION IN HSD3B1 AS A NOVEL BIOMARKER IN PROSTATE CANCER
$561,600Regents Of The University Of Michigan · · FY2015 · Department of the Army
TARGETING TMPRSS2-ERG IN PROSTATE CANCER
$561,600Dana-Farber Cancer Institute, Inc. · · FY2013 · Department of Defense
PATTERNS OF CARE, UTILIZATION, AND OUTCOMES OF TREATMENTS FOR LOCALIZED PROSTATE CANCER
$561,600University Of California, Los Angeles · · FY2008 · Department of Defense
NOVEL DIFFUSION-WEIGHTED MRI FOR HIGH-GRADE PROSTATE CANCER DETECTION
$561,600University Of Illinois · · FY2015 · Department of the Army
ROLE OF GGAP2/PIKE-A IN PROSTATE CANCER PROGRESSION
$561,594Baylor College Of Medicine · · FY2008 · Department of Defense
Transmembrane Proteases and Prostate Carcinogenesis
$561,546Robert Vessella · University Of Washington · P01 · FY2011 · CA
Harnessing the CRL4 ubiquitin ligase for antagonizing colorectal carcinogenesis
$561,496Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA